These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8750478)

  • 1. Assessment of quality of life in clinical trials of the British Medical Research Council.
    Machin D
    J Natl Cancer Inst Monogr; 1996; (20):97-102. PubMed ID: 8750478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. United Kingdom Cancer Research Campaign approach to quality-of-life research in cancer clinical trials.
    Hopwood P
    J Natl Cancer Inst Monogr; 1996; (20):103-5. PubMed ID: 8750479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective.
    Beitz J; Gnecco C; Justice R
    J Natl Cancer Inst Monogr; 1996; (20):7-9. PubMed ID: 8750460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies.
    Gotay CC
    J Natl Cancer Inst Monogr; 1996; (20):1-6. PubMed ID: 8750459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office.
    Fayers PM; Hopwood P; Harvey A; Girling DJ; Machin D; Stephens R
    Eur J Cancer; 1997 Jan; 33(1):20-8. PubMed ID: 9071894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities.
    van Leeuwen M; Efficace F; Fosså SD; Bolla M; De Giorgi U; de Wit R; Holzner B; van de Poll-Franse LV; van Poppel H; White J; Collette L; Osanto S; Aaronson NK; ; ;
    Eur J Cancer; 2014 Jul; 50(11):1957-63. PubMed ID: 24820932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in clinical cancer trials: experience and perspective of the European Organization for Research and Treatment of Cancer.
    Kiebert GM; Kaasa S
    J Natl Cancer Inst Monogr; 1996; (20):91-5. PubMed ID: 8750477
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality-of-life research in the Pediatric Oncology Group: 1991-1995.
    Bradlyn AS; Pollock BH
    J Natl Cancer Inst Monogr; 1996; (20):49-53. PubMed ID: 8750466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Dancey J; Zee B; Myles J; Pater J
    J Natl Cancer Inst Monogr; 1996; (20):107-11. PubMed ID: 8750480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-of-life outcomes in oncology.
    Siddiqui F; Kachnic LA; Movsas B
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):165-85. PubMed ID: 16580562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer and Leukemia Group B (CALGB).
    Kornblith AB
    J Natl Cancer Inst Monogr; 1996; (20):67-71. PubMed ID: 8750469
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer.
    Kiebert GM; Curran D; Aaronson NK
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):561-9. PubMed ID: 9549805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childrens Cancer Group (CCG).
    MacLean WE
    J Natl Cancer Inst Monogr; 1996; (20):87-8. PubMed ID: 8750475
    [No Abstract]   [Full Text] [Related]  

  • 14. Model for quality-of-life research from the Cancer and Leukemia Group B: the telephone interview, conceptual approach to measurement, and theoretical framework.
    Kornblith AB; Holland JC
    J Natl Cancer Inst Monogr; 1996; (20):55-62. PubMed ID: 8750467
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of quality of life outcomes on clinical practice.
    Ganz PA
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):61-5. PubMed ID: 8608057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience.
    Osoba D; Bezjak A; Brundage M; Pater J;
    Value Health; 2007; 10 Suppl 2():S138-45. PubMed ID: 17995472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Southwest Oncology Group (SWOG).
    Loll LC; Moinpour CM; Feigl P
    J Natl Cancer Inst Monogr; 1996; (20):83-5. PubMed ID: 8750474
    [No Abstract]   [Full Text] [Related]  

  • 18. [Health related quality of life and endpoints in oncology].
    Bonnetain F
    Cancer Radiother; 2010 Oct; 14(6-7):515-8. PubMed ID: 20674446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate End Points and Their Validation in Oncology Clinical Trials.
    Zhao F
    J Clin Oncol; 2016 May; 34(13):1436-7. PubMed ID: 26951314
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improving quality of end-of-life care. A possible and necessary change].
    Costantini M; Beccaro M; Di Leo S
    Epidemiol Prev; 2011; 35(3-4):229-33. PubMed ID: 21914920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.